Janssen Search
Search results
Anthony Williamson, PH.D.
As Head of Technology at the Janssen Prevention Center, Anthony Williamson has broad responsibility for acquiring and developing innovative technologies for preventing non-communicable diseases. He brings to this role an impressive track record for ...
Artificial Intelligence
Can Artificial Intelligence Change How We Discover New Medicines? Sep 04, 2018 The big question right now is: Can artificial intelligence – also known as AI- change how scientist discover new medicines? Yes- According to new research from scientists at ...
Research & Development
Research & Development Dec 12, 2019 Article Block Text: Our research pipeline is rich with transformational science reflecting our unique approach to innovation. order: 1 ...
PH Development
Development Investing in ways to improve the diagnosis gap and improve survival rates. At Janssen, we are committed to addressing the diagnostic gap and improving survival rates. We have undertaken extensive research to map out the patient journey in ...
Our Vision to Eliminate Prostate Cancer through a Multi-Pronged Approach
Our Vision to Eliminate Prostate Cancer through a Multi-Pronged Approach Prostate cancer is the second most common cancer and the fourth leading cause of cancer death in men worldwide, with an incidence of approximately 1.4 million and mortality of ...
Fighting Infectious Disease in China
Article Type: Infectious Diseases & Vaccines Tackling Infectious Diseases in China For several years Janssen has partnered with Tsinghua University in Beijing, China to host a Public Health Day that featured academia, leading government officials and ...
Alison Chalker, Ph.D.
ALISON CHALKER, PH.D. PORTFOLIO STRATEGY & DATA SCIENCES INTEGRATION LEADER As Strategic Portfolio and Data Sciences Integration Leader for Neuroscience at Janssen Research & Development (R&D), Alison Chalker, Ph.D. leads a team responsible ...
About Our Research & Development
Research & Development at Janssen: Innovations That Transform How Diseases Are Thought of, Managed, Prevented and Intercepted At the Janssen Pharmaceutical Companies of Johnson & Johnson, working on incremental improvements to healthcare is not ...
Our Team: Leading the Fight Against Cancer
Our Team: Leading the Fight Against Cancer At Janssen Oncology, we share a deep passion for scientific innovation and for bringing together the best expertise worldwide to make promising treatments available to patients who are waiting for them. Our ...
Lloyd S. Miller, M.D., Ph.D.
LLOYD S. MILLER, M.D., PH.D. VICE PRESIDENT IMMUNODERMATOLOGY DISEASE AREA LEADER Lloyd S. Miller, M.D., Ph.D., is Vice President, Immunodermatology Disease Area Leader for the Immunology Therapeutic Area at Janssen Research & Development, LLC. In ...